Key facts
- This page summarizes Chad Gassert's Form 3 filing for ANI PHARMACEUTICALS INC (ANIP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Nov 2021, 15:43.
Chad Gassert - 19 Nov 2021 Form 3 Insider Report for ANI PHARMACEUTICALS INC (ANIP)
- Reporting relationship
- SVP - CORP. DEV. & STRATEGY
- Issuer ticker
- ANIP
- Reported as of
- 19 Nov 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 23 Nov 2021, 15:43:45 UTC
- Next SEC filing
- 22 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chad Gassert
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Chad Gassert filed Form 3 for ANI PHARMACEUTICALS INC (ANIP) on 23 Nov 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
No securities are beneficially owned.